Concurrently, others showed that rapamycin treatment could reverse AD-like pathology, mitochondrial abnormalities, and cognitive deficits via decreasing mTOR signaling in the hippocampus in a diabetic mice model [236]. Here, MTOR is linked to Alzheimer disease.